Novartis has reportedly collaborated with healthcare company USV to market its anti-diabetic product Galvus, in a move that would pitch the pharma company directly against bMerck/b. Novartis plans to pitch this against bMerck/b`s Januvia by b.../b
FDA Approves ZOLINZA as long as the Composition apropos of Hypodermic Manifestations rapport Patients in line with Skinny T-cadre Lymphoma Who Sire Tried and Ineffective Diverse Therapies ZOLINZA is Merck?s measly anticancer shading ...
